Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Non-Small-Cell Lung × Drug Therapy × Clear all

Phase

Phase 2 80 Phase 3 23 Phase NA 18 Phase 1 13 Phase 1/2 8 Phase 4 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 5 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Pancreatic Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Neoplasms 2 Sarcoma, Ewing 1 SCLC 1 Retinoblastoma 1 Osteosarcoma 1 Oligometastatic Disease 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Mouth Neoplasms 1 Lymphoma, Follicular 1 Lymphoma 1 Locally Advanced Resectable Rectal Cancer 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1

Interventions

Pemetrexed 13 Carboplatin 13 Docetaxel 11 Cisplatin 11 pembrolizumab 9 Paclitaxel 8 Gemcitabine 7 Erlotinib Hydrochloride 4 Bevacizumab 4 anlotinib 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Gefitinib 3 Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 cobimetinib 2 cemiplimab 2 auricularum 2 atezolizumab 2 apatinib 2 Vemurafenib 2 Surgical Procedures, Operative 2 Standard of Care 2 Specimen Handling 2 Ramucirumab 2 Calcium Dobesilate 2 trametinib 1 toripalimab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05255302 2025-04-01

DIAL

Intergroupe Francophone de Cancerologie Thoracique

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡